drug
levoketoconazole
Marketedupdated 3mo agoby $XERS Xeris Biopharma Holdings, Inc.
Approvedcommunity read0 votes
all catalysts(0)
nothing on the calendar yet
Trials studying levoketoconazole
Patent cliff
source: FDA Orange Bookfirst barrier falls
Dec 30, 2026
138 days
Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.
patents (9)
- Mar 2, 2040method-of-use (U-3282)US 11020393
- Mar 2, 2040method-of-use (U-3282)US 11278547
- Mar 2, 2040method-of-use (U-3821)US 11903940
- Mar 2, 2040method-of-use (U-4236)US 12377096
- May 3, 2028method-of-use (U-3283)US 99189841.7y
- Jan 10, 2026method-of-use (U-3283)US 10098877
- Jan 10, 2026method-of-use (U-3283)US 10517868
- Jan 10, 2026method-of-use (U-3283)US 10835530
- Jan 10, 2026method-of-use (U-3283)US 11478471
FDA exclusivities (2)
- Dec 30, 2028ODE-385Orphan Drug (7y)2.4y
- Dec 30, 2026NCE*NCE*138d
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 25m ago
Found something off?
comments(0)
5-min edit window · permanent after that